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Knockout of the ubiquitously expressedmiRNA-17∼92 cluster inmice produces a lethal developmental lung defect,
skeletal abnormalities, and blocked B lymphopoiesis. A shared target of miR-17∼92 miRNAs is the pro-apoptotic
protein BIM, central to life-death decisions in mammalian cells. To clarify the contribution of miR-17∼92:Bim
interactions to the complex miR-17∼92 knockout phenotype, we used a system of conditional mutagenesis of the
nine Bim 3′ UTR miR-17∼92 seed matches. Blocking miR-17∼92:Bim interactions early in development phe-
nocopied the lethal lung phenotype of miR-17∼92 ablation and generated a skeletal kinky tail. In the hematopoietic
system, instead of causing the predicted B cell developmental block, it produced a selective inability of B cells to
resist cellular stress; and prevented B and T cell hyperplasia caused by Bim haploinsufficiency. Thus, the interaction
ofmiR-17∼92with a single target is essential for life, and BIM regulation bymiRNAs serves as a rheostat controlling
cell survival in specific physiological contexts.
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Mature microRNAs (miRNAs) are 22-nucleotide (nt) non-
coding RNAs that regulate gene expression. They affect a
wide range of cellular processes involved in organismal
development and pathology (Bartel 2018). miRNAs guide
the RNA-induced silencing complex (RISC) containing
Argonaute (AGO) proteins to partially complementary se-
quences on messenger RNAs (mRNAs), leading to inhibi-
tion of translation and/or acceleratedmRNAdecay (Bartel
2018). The mammalian genome harbors thousands of
miRNA genes, many of which are organized into tran-
scriptionally coregulated clusters such as miR-17∼92.
The specificity of miRNA:mRNA interactions largely
depends on themiRNA6- to 8-nt “seed” region, which ex-
hibits Watson-Crick complementarity with the “seed
match” region in the cognate mRNA, located mostly in
its 3′ untranslated region (UTR). The identification of con-
served seed matches is the key element of in silico
miRNA target predictions (Rajewsky 2006; Bartel 2009,
2018), which typically come up with hundreds of poten-
tial binding sites across the transcriptome. These predic-
tions can be experimentally validated by measuring
gene expression changes (Lim et al. 2005), reporter assays
(Krek et al. 2005), directly detecting AGO binding sites
and predicting seed matches within these sites (Hafner
et al. 2010; Helwak et al. 2013; Grosswendt et al. 2014),
or by identifying physical miRNA:target interactions as
chimeric reads in AGO cross-linking and immunoprecip-
itation (CLIP) data (Grosswendt et al. 2014). While such
data point to a multifactorial nature of miRNA control,
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they often fall short of identifying functionally important
miRNA:target interactions in specific cellular contexts.
Here, small numbers of target genes, even single targets,
may be critical, as suggested by studies in the murine he-
matopoietic system where target gene mutation could
mimic or rescue a miRNA knockout phenotype (Xiao
and Rajewsky 2009). The vital importance of direct con-
trol of a single target gene by a miRNA in development
was demonstrated in the nematode Caenorhabditis ele-
gans by seed match mutagenesis (Ecsedi et al. 2015;
McJunkin and Ambros 2017), extending earlier experi-
ments in mice where seed match mutation for one partic-
ular hematopoietic miRNA,miR-155, had provided direct
evidence formajor functional roles of distinct single target
genes in different immunological contexts (Dorsett et al.
2008; Teng et al. 2008; Lu et al. 2014, 2015). Although
miR-155 and hundreds of its mRNA targets are abundant-
ly expressed throughout the immune system, the set of
transcripts physically bound bymiR-155 is unique to indi-
vidual immune cell subsets (Hsin et al. 2018).
In the present study,weuse conditional seedmatchmu-
tagenesis of a single, broadly expressed, and physiological-
ly critical target gene, Bcl2l11, to determine the impact of
its direct control by a set of equally broadly expressed, vi-
tal miRNAs, the miR-17∼92 cluster, in different cellular
contexts.
Bcl2l11, encoding the pro-apoptotic protein BCL-2 in-
teracting mediator of cell death (BIM), has evolved in its
3′ UTR seed matches for multiple members of the miR-
17∼92 cluster (Koralov et al. 2008; Ventura et al. 2008).
BCL-2-family proteins initiate (e.g., BIM, PUMA, BAX)
or prevent (e.g., BCL-2, BCL-XL, MCL-1) mitochondrial
apoptosis through complex protein interactions, thereby
executing life-death decisions under stress conditions
and in normal development and tissue homeostasis
(Labi et al. 2006; Tuzlak et al. 2016). In mice, combined
moderate reduction of MCL-1 and BCL-XL caused devel-
opmental apoptosis that could be prevented by the addi-
tional loss of a single Bim allele (Grabow et al. 2018). In
Caenorhabditis elegans, repression of the BIM homolog
EGL-1 through cooperative binding of miR-35 and miR-
58 prevented developmental apoptosis (Sherrard et al.
2017).
The miR-17∼92 polycistronic transcript is processed to
produce six mature miRNAs categorized into four fami-
lies of distinct target specificity (Mogilyansky and Rigout-
sos 2013); an allelic series of miR-17∼92-mutant mice
demonstrated cooperation and specialization among
these miRNAs (Han et al. 2015). In line with its abun-
dance, recent work has uncovered broad functions in de-
velopment and tissue homeostasis (Mogilyansky and
Rigoutsos 2013; Labi et al. 2019). Thus, germ line deletion
of themiR-17∼92 cluster in mice led to perinatal lethality
due to multi-organ failure, prominently improper lung
development (Ventura et al. 2008). On the other hand, am-
plification and overexpression of miR-17∼92 is frequently
observed in human cancers (Ota et al. 2004; He et al. 2005;
Mogilyansky and Rigoutsos 2013), and its oncogenic prop-
erties have been confirmed in mouse models of B cell pa-
thologies (Jin et al. 2013).
BIM has repeatedly emerged as a potential critical miR-
17∼92 target (Koralov et al. 2008; Ventura et al. 2008;
Molitoris et al. 2011; Li et al. 2014). Thus, targeted dele-
tion of DICER (an enzyme critically involved in miRNA
processing) or miR-17∼92 in mice coincided with a strong
increase in BIM, massive apoptosis, and a complete block
in early B cell development (Koralov et al. 2008; Ventura
et al. 2008). This phenotype could be partially rescued
by BIM-deficiency or ectopic expression of BCL-2. Overex-
pression of miR-17∼92 in mouse lymphocytes caused fa-
tal autoimmunity associated with reduced BIM levels
(Xiao et al. 2008). However, although supported by report-
er assays in vitro, none of these experimental results
necessarily reflects direct miR-17∼92:Bim interactions.
Other regulators of lymphocyte biology, such as Phospha-
tase and tensin homolog (PTEN), are also jointly targeted
by the miR-17∼92 miRNAs (Mogilyansky and Rigoutsos
2013). Given that BIM transcription can be positively reg-
ulated by PTEN (Xiao and Rajewsky 2009), miR-17∼92
may control BIM levels indirectly, via repressing PTEN.
Further confusing the situation is evidence from com-
bined knockout and rescue experiments arguing against
miR-17∼92-mediated control of BIM and PTEN in B cell
development (Lai et al. 2016).
In order to assess the impact of direct miR-17∼92:Bim
interactions beyond the B cell lineage and throughout de-
velopment, we generated a system of conditional muta-
genesis in the mouse, which allows exchange of the
wild-type Bim 3′ UTR against a miR-17∼92 seed match
mutated counterpart in a Cre-dependent manner.
Results
An engineered Bim allele allowing conditional
inactivation of miR-17∼92 seed matches
Using a computational approach (Krek et al. 2005), we
scored allmouse 3′ UTRs for combinations of binding sites
for miR-17∼92 miRNAs. The Bim 3′ UTR was, genome-
wide, one of the top scoring 3′ UTRs with nine putative
miR-17∼92 sites (Fig. 1A). To collectively disrupt miR-
17∼92:Bim interactions, we introduced three point muta-
tions into each of the predicted seedmatches in a targeting
vector which would allow Cre-mediated replacement of
the endogenouswild-typeBim 3′ UTRby itsmutant coun-
terpart in vivo (Fig. 1B,C).Correct homologous recombina-
tion in the targeted embryonic stem cells was verified by
Southern blotting (Supplemental Fig. S1A,B), and after
germ line transmission, themutant Bim locus, designated
Bim3′UTRF, was combined with the hematopoietic line-
age-specific Vav-cre (de Boer et al. 2003), the B lineage-
specific Mb1-cre (Hobeika et al. 2006), and the germline-
expressed CMV-cre (Schwenk et al. 1995) transgenes. In
the latter case, CMV-cre transgene-negative mice hetero-
zygous for the mutant (Bim3′UTRmut) allele were inter-
crossed to generate homozygous mutant animals
(Bim3′UTRmut/mut) that are defective for miR-17∼92:Bim
interactions in all body tissues. PCR on cells from Mb1-
cre and Mb1-cre; Bim3′UTRF/F mice demonstrated effi-
cient and selective Cre-mediated 3′ UTR replacement
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from the early pro-B cell stage on (Fig. 1D; Supplemental
Fig. S1C), and Sanger sequencing confirmed the presence
of all point mutations (Supplemental Fig. S1D).
Finally, using AGO2 Photoactivatable-Ribonucleoside
CLIP (AGO2 PAR-CLIP) technology (Hafner et al. 2010),
we assessed whether the seed match mutations intro-
duced into the Bim 3′ UTR indeed precluded interaction
with the miR-17∼92 miRNAs. This analysis was done
in Abelson Virus transformed pro-B cells (Abl-B cells),
whichwe generated fromwild-type andBim3′UTRmut/mut
E14.5 fetal livers knowing that these cells express both
BIM and miR-17∼92, can be expanded to large numbers
(Rosenberg et al. 1975), and incorporate 4-thiouridine
(4SU) sufficiently well (Supplemental Fig. S2A–D). Focus-
ing on 21-nt windows surrounding the nine putative miR-
17∼92 seedmatches in the Bim3′ UTR (A-I) and excluding
reads lacking T-to-C transitions, we found differential
seed match coverage in the wild type, with one miR-19
and two miR-92 seed matches codominating, while in
the mutant 3′ UTR miR-17∼92 binding was completely
abolished (Fig. 2A,B; Supplemental Fig. S2E,F). Significant
differential coverage was not found in the 3′ UTR of Pten,
another top scoring “combinatorial” miR-17∼92 target
gene (Fig. 2C). Bim 3′ UTR mutagenesis did not affect
the concentrations of mature miRNAs including miR-
17∼92 in Abl-B cells (Fig. 2D).
Together, these results demonstrate functionality and
efficiency of our mouse model for in vivo conditional
seed-match inactivation.
Disruption of miR-17∼92:Bim 3′ UTR interactions in the
germ line leads to neonatal lethality
Whenmice carrying one mutant Bim 3′ UTR allele in the
germ line were inter-crossed, no homozygous mutant
pups were identified at weaning, suggesting that the dis-
ruption of miR-17∼92:Bim interactions early in develop-
ment is lethal. Timed mating between Bim3′UTRmut/+
animals resulted in embryonic genotypes consistent
with Mendelian ratios until E18.5 (Supplemental Fig.
S3A), indicating that Bim3′UTRmut/mut pups die during
or after birth. We therefore recovered E18.5 embryos by
Caesarean section (CS). In six litters examined, all wild-
type and heterozygous animals established rhythmic
breathing, lively movement, and a pink skin color within
minutes. In contrast, Bim3′UTRmut/mut neonates took
short, gasping breaths, showed continuous signs of respi-
ratory distress, quickly became cyanotic, and died within
the first 30 postnatal minutes. Overall, taking 21 litters of
timed heterozygous intercrosses into account, from a to-
tal of 101 offspring at weaning only four mice were
Bim3′UTRmut/mut, of which one died at the age of 123 d
for unknown reasons (Fig. 3A,B; Supplemental Fig. S3A).
The three survivors displayed no obvious gross defects ex-
cept for their small size (and correspondingly small-size
organs; not shown), a kinky tail, and slightly decreased
red blood cell numbers at the age of 8 wk (Fig. 3C). They
harbored normal numbers of immune cells of various sub-
sets in lymphoid tissues (Supplemental Table S1).
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Figure 1. An engineered Bim allele allowing the conditional inactivation of miR-17∼92 seed matches. (A) Scheme depicting the nine
putative miR-17∼92 binding sites (A–I) in the Bim 3′ UTR. (B) Conditional in vivo replacement strategy: Upon Cre-mediated excision,
themutated 3′ UTR (red) functionally replaces the wild-type 3′ UTR (black). Blue arrows indicate the genotyping strategy. Targeted allele
F(loxed), deleted allele mut(ated), L (loxP), F (frt), BGH3xpA (3 bovine growth hormone polyadenylation sequences). (C ) Alternate muta-
tions were introduced into each of the putativeBim 3′ UTRmiR-17∼92 seedmatches. Themutations were chosen such as not creating de
novo seed matches for any known miRNA (miRBase Release 18). Lowercase (mutated nt), black (poorly conserved), red (conserved be-
tweenmouse and human). (D) Efficient and cell type-specificCre-mediatedBim 3′ UTR replacement in vivo from early B cell development
on (pro-B cells) is shown by PCR on various B cell subsets and myeloid cells FACS-sorted from bone marrow.
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E18.5 Bim3′UTRmut/mut embryos displayed moderately
reduced body weight compared to their wild-type siblings
(Fig. 3D) and a kinky tail phenotype with 100% pene-
trance (Fig. 3E), an abnormality that we also found in
the rare survivors (Fig. 3C). Cell counts of liver, thymus,
platelets, white and red blood cells, and hemoglobin levels
were normal, suggesting normal blood formation and ox-
ygenation before birth (Supplemental Fig. S3B,C) and in
adult survivors (Supplemental Table S1). Because of the
respiratory distress of Bim3′UTRmut/mut newborns, we
paid special attention to the innervation of the diaphragm
and brainstem respiratory neurons but failed to detect any
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alterations (Supplemental Fig. S3D,E). As E18.5
Bim3′UTRmut/mut embryos had significantly reduced
lung weight (Fig. 3F), we turned our attention to the lungs
themselves.
miR-17∼92:Bim interactions are essential for lung
development
Consistentwith the respiratory distress and reduced organ
weight, lungs fromBim3′UTRmut/mut E18.5 embryoswere
of hypoplastic appearance and showed collapsed alveolar
spaces and increased tissue density (Fig. 4A; Supplemental
Fig. S4A). In E18.5 Bim3′UTRmut/mut hearts, dilatation
of the atria and hypertrophy of the ventricles were noticed
(Supplemental Fig. S4A). This phenotype might be caused
by hypertension in the pulmonary circulation due to
the lack of lung expansion. When placed in PBS 15 min
after CS, lungs isolated from E18.5 wild-type neonates
floated whereas lungs from mutant animals sank, in-
dicating that no aeration had occurred (Supplemental
Fig. S4B). Consistently, lungs fromBim3′UTRmut/mut neo-
nates did not show evidence of air in the distal airways
(Fig. 4B).
Proteomic analysis revealed, among others, an under-
representation of CC10 (P = 0.0003) (Stripp et al. 1992),
surfactant protein A1 (P= 0.0271) (Korfhagen et al. 1996),
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and SLC34A2 (P= 0.0174) (Feild et al. 1999), indicative of
distal airway cell depletion, specifically of club cells and
epithelial type II pneumocytes in Bim3′UTRmut/mut lungs
(Supplemental Table S2).
If miR-17∼92-mediated BIM repression is fundamental
to the observed lung phenotype, BIM levels should be
higher in E18.5 Bim3′UTRmut/mut lungs as compared to
controls. Indeed, Bim mRNA expression was elevated in
the mutant lungs, a difference not observed in fetal liver,
an organ without apparent phenotypic alterations (Fig.
4C). This correlated with elevated BIM protein in
Bim3′UTRmut/mut lungs (Fig. 4D,E), whereas expression
of miR-17∼92 miRNAs remained unchanged (Fig. 4F).
Immunohistochemistry revealed a moderate, albeit not
significant, increase in the number of apoptotic cells in
the pulmonary parenchyma and the bronchial epithe-
lium of E18.5 Bim3′UTRmut/mut lungs (Supplemental
Fig. S4A).
The inability of Bim3′UTRmut/mut neonates to aerate
their lungs to a functional level phenocopies the lung hy-
poplasia and resulting lethality inmiR-17∼92−/− neonates
(Ventura et al. 2008; Han et al. 2015). Altogether, our find-
ings provide in vivo evidence that repression of BIM by
miR-17∼92 is critical for proper lung development and
of vital importance.
Hematopoiesis including B lymphopoiesis is not
detectably affected upon disruption of miR-17∼92:Bim
3′ UTR interactions in vivo
BIM limits the survival of hematopoietic stem/progenitor
cells during transplantation or cytokine deprivation (Nor-
digården et al. 2009; Labi et al. 2013; Kollek et al. 2017).
However, restricting seed match mutagenesis to the he-
matopoietic system using a Vav-cre transgene, we failed
to detect phenotypic alterations in hematopoietic progen-
itors or their progeny (Fig. 5A–C), in accord with our
observations on the rare survivors of miR-17∼92 seed
match mutation in the germ line (Supplemental Table
S1). PCR on cells FACS-sorted from Vav-cre;Bim3′UTRF/+
and Vav-cre;Bim3′UTRF/F mice demonstrated efficient
and selective Cre-mediated 3′ UTR replacement in hema-
topoietic progenitors (LSK cells), pro-B cells, andmature B
and T cells (Fig. 5D; Supplemental Fig. S5A). These results
are in line with previous reports suggesting no major role
for miR-17∼92 in hematopoiesis, with the exception of
the severe block of B cell development accompanied by
massive BIMupregulation, inmiR-17∼92 knockouts (Kor-
alov et al. 2008; Ventura et al. 2008).
To follow up on this discrepancy, we performed a de-
tailed analysis of B lymphopoiesis in mice in which
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and Bim3′UTRmut/mut lungs (n=3–4 mice per genotype). Scale bar: 200 µm. (B) Fetal lungs isolated from E18.5 neonates 15 min upon ex-
teriorization. Wild-type embryos aerate their lungs (left), Bim3′UTRmut/mut embryos insufficiently aerate their lungs (right). Representa-
tive photographs are shown (n =3 mice per genotype). Scale bar: 1 mm. (C ) qRT-PCR analysis for Bim mRNA expression in total organ
extracts of fetal liver and lung of wild-type and Bim3′UTRmut/mut E18.5 littermate embryos (n =4 mice per genotype). (D,E) Immunoblot
for BIM and PTEN protein in lung extracts of wild-type and Bim3′UTRmut/mut E18.5 littermate embryos (n =4–5 mice per genotype).
(F ) E18.5 Bim3′UTRmut/mut lungs (n=5) show no change in the global levels of mature miRNAs as compared to wild-type (n=4) lungs
(nCounter gene expression analysis, Pearson correlation). (∗) P <0.05, (∗∗) P <0.01. Data are presented as mean±SD.
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miR-17∼92:Bim 3′ UTR interaction was selectively ablat-
ed in the B cell lineage through the Mb1-cre transgene.
Young Mb1-cre;Bim3′UTRF/F mice showed no gross de-
fects in steady-state B cell development as suggested by
normal percentage (Fig. 6A; Supplemental Fig. S5B) and
number (Supplemental Fig. S5B) of pro-B, pre-B, and im-
mature IgM+ bone marrow B cells. Similarly, peripheral
maturation (transitional T1 and T2 B cells) and homeosta-
sis of mature B cells (follicular [FO] B cells and marginal
zone [MZ] B cells) in the spleen (Fig. 6B; Supplemental
Fig. S5C) as well as recirculating mature B cells in the
bone marrow (Fig. 6A; Supplemental Fig. S5B) were unaf-
fected. A similar situation was encountered in aged
Mb1-cre;Bim3′UTRF/F mice (Supplemental Fig. S5D,E).
Although we could not detect significant changes of Bim
mRNA levels in various B cell subsets in comparison to
control cells (Fig. 6C), BIM protein abundance determined
by flow cytometry was moderately increased in pro- and
pre-B cells ex vivo (Fig. 6D; Supplemental Fig. S6A). How-
ever, this did not translate into significantly more apopto-
tic cells (Supplemental Fig. S5F).
Additional attempts to find evidence for an impact of
miR-17∼92:Bim interactions in the B cell compartment
also failed. Thus, Bim heterozygosity did not overcome
the block at the pro- to pre-B cell transition caused by
miR-17∼92 deficiency (Fig. 6E). There were also no differ-
ences in the survival of splenic B cells from Mb1-cre and
Mb1-cre;Bim3′UTRF/F mice upon in vitro exposure to
B cell activating factor (Baff) (Supplemental Fig. S6B) or
upon activation by α-IgM antibodies plus interleukin-4
(IL4) or lipopolysaccharide (LPS) (Supplemental Fig.
S6C). In all these conditions, loss of BIMhad been reported
to exert anti-apoptotic activity (Oliver et al. 2006; Woess
et al. 2015).
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Figure 5. Hematopoiesis is not detectably affected upon disruption of miR-17∼92:Bim interactions. (A) Flow cytometry analysis of bone
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CD11b−B220−NK1.1−CD3−Sca-1+cKit+CD34+CD135+), ST-HSC (Ter119−CD11b−B220−NK1.1−CD3−Sca-1+cKit+CD34+CD135−),
LT-HSC (Ter119−CD11b−B220−NK1.1−CD3−Sca-1+cKit+CD34−CD135−), HSC SLAM (Ter119−CD11b−B220−NK1.1−CD3−Sca-1+cKit+
CD48−CD150+); (n=4–6 mice per genotype). (B) Flow cytometry analysis of thymocyte subsets of Vav-cre and Vav-cre;Bim3′UTRF/F
mice: DN1 (Ter119−CD11b−B220−NK1.1−gδTCR−CD4−CD8−CD25−CD44+), DN2 (Ter119−CD11b−B220−NK1.1−gδTCR−CD4−CD8−
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lymphoid progenitors), CMP (common myeloid progenitors), GMP (granulocyte-monocyte progenitors), MEP (megakaryocyte-erythroid
progenitors), MPP (multipotent progenitors), ST-HSC (short-term hematopoietic stem cells), LT-HSC (long-termHSC), HSC SLAM (long-
termHSC; SLAMmarkers), DN (double negative), DP (double positive), SP (single positive). Eight- to 12-wk-oldmicewere analyzed. Data
are presented as mean± SD.
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Figure 6. Specific disruption of miR-17∼92:Bim interactions does not detectably affect B cells. (A,B) Flow cytometry plots depict bone
marrow B cell subsets: total (B220+CD19+), mature recirculating (B220hiCD19+AA4.1−IgM+), immature IgM+ (B220loCD19+AA4.1+IgM+),
pre-B (B220loCD19+AA4.1+IgM−CD25+ckit−), and pro-B (B220hiCD19+AA4.1+IgM−CD25−ckit+); and splenic B cell subsets: total B2
(B220+CD19+), follicular (FO) (B220+CD19+AA4.1−IgMlow/+CD1dlow/+), marginal zone (MZ) (B220+CD19+AA4.1−IgMhighCD1dhigh), tran-
sitional 1 (T1) (B220+CD19+AA4.1+IgMhighCD23−), and transitional 2 (T2) (B220+CD19+AA4.1+IgMhighCD23+). Red arrows show gating
strategy, numbers adjacent to regions represent percent within parent population. Plots are representative of 4–10 mice per genotype.
(C ) qRT-PCR for Bim expression in FACS-sorted pro-B, large pre-B (FSC-Ahigh), small pre-B (FSC-Alow), and immature IgM+ B cells from
control (either Mb1-cre or Vav-cre) and either Mb1-cre;Bim3′UTRF/F or Vav-cre;Bim3′UTRF/F mice (n =6–10 mice per genotype).
(D) Flow cytometry analysis of BIM protein in B cell subsets of the indicated genotypes. Colors represent samples that were processed
as a mixture with the samewild-type control cells carrying a hCD2 reporter (n=3mice per genotype). (MFI) Mean fluorescence intensity.
(E) Pro-B/pre-B ratio is based on flow cytometry analysis of mice of the indicated genotypes (n =4–7 mice per genotype). (F ) Number of
splenic FO B, CD4+, and CD8+ T cells of wild-type, germline heterozygous Bim3′UTRmutant (Bim3′UTRmut/+), Bim+/−, and haploinsuf-
ficient Bimmice that harbor the germlinemutated Bim 3′ UTR in the remaining Bim allele (Bim3′UTRmut/−) (n=5–7mice per genotype).
(G) Flow cytometry analysis of BIM protein in splenic FO B cells. Samples were processed as a mixture with Ly5.1 wild-type splenocytes.
BIM expression was normalized to Ly5.1 FO B cells in the same tube (n= 5–23 mice per genotype). (∗) P <0.05, (∗∗) P<0.01, (∗∗∗) P<0.005.
Data are presented as mean± SD; 7- to 9-wk-old mice were analyzed.
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Bim heterozygosity results in lymphoproliferation which
is reverted by miR-17∼92 seed match mutation
While lymphopoiesis proceeded normally in the absence
of miR-17∼92:Bim interactions, this was not the case in
Bim heterozygous mice, which displayed lymphocyte hy-
perplasia, in accord with earlier work (Fig. 6F; Bouillet
et al. 1999; Liu et al. 2018). In this situation, miR-17∼92
seed match mutation in the functional Bim allele correct-
ed the B and T cell hyperplasia (Fig. 6F) and BIM levels in
FO B cells. This supports the concept developed by
Mukherji and colleagues (Mukherji et al. 2011) that the
relative concentrations of miRNAs and their target
mRNAs determine thresholds of miRNA control and in-
dicates that, inwild-typemouse lymphocytes, the relative
Bim mRNA levels are too high for efficient direct miR-
17∼92 control, in contrast to the situation in the heterozy-
gous Bimmutants.
Repression of Bim by miR-17∼92 promotes progenitor B
cell fitness during stress responses
In accord with our demonstration that in wild-type mice,
miR-17∼92:Bim interactions do not affect B lympho-
poiesis in steady-state, they also appeared irrelevant in
competitive bone marrow transplantation experiments
(Supplemental Fig. S7A), where loss of BIM is advanta-
geous for the fitness of most hematopoietic cell types
(Labi et al. 2013). However, a different picture emerged
when we FACS-sorted pro-B cells from the bone marrow
ofMb1-cre andMb1-cre;Bim3′UTRF/Fmice andcultivated
these cells in the presence of IL-7 (Hardy and Hayakawa
2001). Under these conditions, pro-B cells proliferate
yet also undergo apoptosis, which ultimately causes the
collapse of the cultures. As evidenced by Annexin V stain-
ing, Mb1-cre;Bim3′UTRF/F pro-B cells displayed increased
fractions of apoptotic cells when compared to Mb1-cre
control cells (Fig. 7A; Supplemental Fig. S7B). This corre-
sponded to a substantial reduction of cell numbers over
time (Fig. 7B; Supplemental Fig. S7C). Increased apoptosis
coincided with elevated BIM protein in Mb1-cre;
Bim3′UTRF/F pro-B cells (Fig. 7C), and genotyping con-
firmed that the Mb1-cre;Bim3′UTRF/F pro-B cells indeed
carried the Bim mutant alleles (Supplemental Fig. S7D).
Thus, disruption of miR-17∼92:Bim 3′ UTR interactions
sensitizespro-Bcells tostress elicitedbyexvivocultivation.
This became most dramatically apparent when we as-
sessed the in vitro colony forming potential of B cell pro-
genitors in semisolid medium. Compared to the controls,
Mb1-cre;Bim3′UTRF/F and Vav-cre;Bim3′UTRF/F bone
marrow displayed strongly diminished colony formation
(Fig. 7D; CFU pre-B), with a fraction of the cells having
(partially) escaped 3′ UTR replacement (Supplemental
Fig. S7E). Reduced colony formation was restricted to
B cells, as undermyeloid priming conditions all genotypes
produced equal colony numbers (Fig. 7D; CFU myeloid).
Discussion
While miRNAs may fine tune transcriptional and signal-
ing networks (Bartel and Chen 2004), there is also evi-
dence that miRNA control of single key target genes can
play a critical functional role in vivo. Apart frommore in-
direct approaches (Xiao and Rajewsky 2009), most con-
vincing in this regard are experiments in which such
genes were genetically identified through miRNA seed
match mutation (Dorsett et al. 2008; Teng et al. 2008;
Kadener et al. 2009; Bassett et al. 2014; Lu et al. 2014,
2015; Ecsedi et al. 2015; McJunkin and Ambros 2017).
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Figure 7. miR-17∼92-mediated repression of BIM promotes the
fitness of B cell progenitors during stress responses. (A,B) FACS-
sorted pro-B cells (B220hiCD19+AA4.1+IgM−CD25−ckit+) were
placed in medium with IL-7. Live cells were defined as Annex-
inV−TO-PRO-3− and analyzed by flow cytometry over time (n=
3–5mice per genotype). (C ) Representative flow cytometry analy-
sis of BIM protein expression in pro-B cells from twoMb1-cre and
Mb1cre;Bim3′UTRF/F mice, respectively, at culture day 4 (n =6
mice per genotype). (D) Ex vivo colony formation of bonemarrow
pro-/pre-B cells (CFU-pre-B) or myeloid cells (CFU-myeloid) (n=
4–8 mice per genotype). (CFU) Colony forming unit. (∗∗) P< 0.01,
(∗∗∗) P <0.005, (∗∗∗∗) P<0.0001. Data are presented as mean±SD.
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These experiments primarily addressed miRNA control
in specific biological contexts where candidate target
genes emerged from the informed inspection of computa-
tional predictions. The motivation for the present study
arose in a similar situation, namely when we discovered
that miRNA control was essential to prevent apoptosis
during B cell development (Koralov et al. 2008). From
this and parallel work (Ventura et al. 2008), it became
clear that one cluster of miRNAs, miR-17∼92, played a
prominent role in this process, with the pro-apoptotic
BIM protein being a potential key functional target, given
the evolutionarily conserved “combinatorial” accumula-
tion of miR-17∼92 seed matches in the Bim gene 3′ UTR.
Considering the close to ubiquitous expression of both
themiR-17∼92miRNAs and BIM, albeit at varying levels,
the broad impact of BIM on cellular life-death decisions,
the dramatic developmental phenotypes upon miR-
17∼92 knock-out, andwidespreadmiR-17∼92 overexpres-
sion in human cancers, the problem gained a broader
perspective.We therefore set out to explore towhat extent
miR-17∼92:Bim interactions control apoptosis in and be-
yond the hematopoietic system by generating a mutant
Bim allele in which the 3′ UTR can be conditionally ex-
changed against a mutant counterpart with all miR-
17∼92 seed matches inactivated. PAR-CLIP experiments
demonstrated that the selected seed match mutations in-
deed prevented miRNA binding to the Bim 3′ UTR. This
corresponded to increased levels of Bim mRNA and pro-
tein in various (mutant) cell types analyzed in later exper-
iments, although averaging over cell populations, the
effects varied and rarely exceeded a factor of two.
We note that we have not yet explored the significance
of the joint targeting of the Bim 3′ UTR by multiple miR-
17∼92miRNAs.While this feature is expected to enhance
the functional efficiency and specificity of the interac-
tions there is also evidence that individual miRNAs of
themiR-17∼92 cluster exert distinct regulatory functions.
Curiously, we did not detect binding of miR-17-5p to the
Bim 3′ UTR in our PAR-CLIP analysis of B cells, despite
the abundance of this miRNA and evolutionarily con-
served seed matches in the Bim 3′ UTR. Perhaps miR-
17-5p binding would be detectable in developing cells of
the lung, given that combined knockout of miR-17-5p
and miR-92 resulted in embryonic lethality (Han et al.
2015).
Does elimination of miR-17∼92 seed matches in the
Bim 3′ UTR have physiological consequences and to
what extent does it mirror the various effects of miR-
17∼92 ablation? Strikingly, Bim seed match mutagenesis
in the germ line reproduced the perinatal lethality of
miR-17∼92 knockout mice, due in both cases to a failure
of the newborns to inflate their lungs. Our experimental
evidence indicates that this failure was lung-intrinsic
and likely reflects dysregulation at late stages of lung de-
velopment. This scenario most easily accommodates the
rare Bim3′UTRmut/mut long-term survivors, where the
lungs did not exhibit detectable histological abnormalities
(data not shown). Apart from a lung phenotypewith >80%
penetrance and reduced body size,Bim3′UTRmut/mutmice
displayed only a single additional macroscopically detect-
able phenotype, namely a kinky tail. Tail deformation has
recently been observed in mice upon genetic interference
with apoptosis control during development (Ke et al.
2018), and miR-17∼92 deficiency has been linked to skel-
etal abnormalities in humans and mice (de Pontual et al.
2011; Han et al. 2015). It is therefore quite in order to
find a pro-apoptotic miR-17∼92 target critically involved
in this context. Note, however, that both in Feingold
syndrome patients and in miR-17∼92 heterozygous or ho-
mozygous knockout mice, the skeletal abnormalities
mainly affected fingers and toes; and that the kinky tail
phenotypewas absent in themiR-17∼92 knockout embry-
os (Ventura et al. 2008). While the comparison of the
mouse mutants is not straightforward because of major
differences of their genetic backgrounds, miR-17∼92
may well affect skeletal development through more than
a single target gene. Most importantly, however, mice
harbor two miR-17∼92 paralog gene clusters whose con-
comitant knockout results in early embryonic lethality
(Ventura et al. 2008), precluding the identification of tail
phenotypes.
In contrast to the lung and skeletal phenotypes, the he-
matopoietic system was not detectably affected at steady
state by ablation of miR-17∼92:Bim interactions. This
seemingly contrasts the severe block of B cell develop-
ment in miR-17∼92 or DICER-deficient animals with
massive BIM up-regulation in the affected cells (Koralov
et al. 2008; Ventura et al. 2008). However, in the case of
DICER deficiency, BIM ablation only moderately rescued
B cell development, and the extent of BIMup-regulation in
both miR-17∼92 or DICER-ablated B cell progenitors by
far exceeded the modest effects we see upon elimination
of miR-17∼92:Bim interactions in other cells. We con-
clude that in the context of B cell development, miR-
17∼92 controls cell survival through mechanisms other
than direct BIM control. This also applies to the loss of he-
matopoietic stem/progenitor and B cells in a model of
acutemiR-17∼92 deletion in adultmice and its partial res-
cue by BIM deficiency (Brinkmann et al. 2018), given that
these cell compartments are unaffected in our mouse
model.
Unexpectedly, however, striking deficits in cellular fit-
ness became apparent when mutant B cells that showed
no phenotype under physiological conditions were ex-
posed to stress conditions exemplified by in vitro cultiva-
tion. Here again, the phenotype was specific for cellular
context in that it did not extend to myeloid cells. De-
creased stress tolerance and the associated reduced cellu-
lar fitness, recurrent themes in the field ofmiRNAcontrol
(Ebert and Sharp 2012), are likely to play a role in vivo
where B cells must compete and respond to internal and
external stimuli.
Taken together, the present study identifies, through
conditional seedmatchmutagenesis, direct miRNA regu-
lation of BIM expression as a rheostat that controls cell
survival in a variety of distinct and diverse cellular and
developmental contexts which are hard to predict. We
make the case for themousemiR-17∼92 cluster,members
of which collectively target the Bim 3′ UTR in an evolu-
tionarily conserved manner, by showing that the
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corresponding interactions are critical for life in lung de-
velopment, control tail morphology, and allow the sur-
vival of B cell progenitors under stress conditions. This
rheostatic control may depend on BIM concentration:
While it plays no role in normal T and B cell development,
the T and B cell hyperplasia seen in Bim haploinsufficient
animals is corrected upon ablation of miR-17∼92:Bim in-
teractions. Further studies will be needed to test whether
the cytoprotective miR-17∼92:Bim relationship operates
in other cellular and developmental contexts where
BCL-2 family proteins are critical regulators of cell sur-
vival. This seems indeed likely as most cells in our body
can be subject to mitochondrial apoptosis and the Bim
3′ UTR is a putative target of multiple miRNAs in addi-
tion to miR-17∼92 (www.targetscan.com). One of these
miRNAs, miR-24, has been specifically invoked in the
control of cardiomyocyte survival, with Bim as a potential
target gene (Guo et al. 2015).
Finally, in a more general context, the present work re-
veals the impact and unforeseen complexity of miRNA
control at the level of a single, vitally important target
gene, demonstrating that the analysis of directmiRNA in-
teractions with individual key targets is essential for the
understanding and rational manipulation of miRNA
control.
Materials and methods
Mice
Flpe (Dymecki 1996), Mb1-cre (Hobeika et al. 2006), Vav-cre (de
Boer et al. 2003), CMV-cre (Schwenk et al. 1995), Bim− (Bouillet
et al. 1999), R26hCD2stopF (Calado et al. 2012), and miR-17∼92F
(Ventura et al. 2008) mice have been described. Ly5.1 mice were
purchased (JAX 002014). Bim3′UTRF mice were generated by
us. Genotyping primers for the Bim3′UTR wild-type, floxed,
and mutant alleles are detailed in Supplemental Table S3. Cycle
conditions: 95°C/5 min; 30 cycles: 95°C/30 sec, 62°C/45 sec,
72°C/45 sec; 72°C/7 min. Animal procedures were approved by
the official review boards (Landesamt für Gesundheit und
Soziales Berlin, LaGeSo G0374/13; Harvard Medical Area Stand-
ing Committee on Animals, #4M0310).
Generation of conditional Bim3′ UTR mutant mice
To collectively disrupt all miR-17∼92:Bim interactions, we mu-
tated three alternate bases in each of the nine PicTar-predicted
(pictar.mdc-berlin.de) Bim 3′ UTR miR-17∼92 seed matches by
PCR-mediated mutagenesis using primers detailed in Supple-
mental Table S3. We flanked a 4.9-kb genomic fragment includ-
ing the entire wild-type Bim exon 4 with loxP sites, which were
inserted into nonconserved intronic sequences. To prevent tran-
scription from the wild-type to the mutant exon, we inserted
three identical copies of the bovine growth hormone polyadeny-
lation sequence (BGH3XpA) downstream of the wild-type exon.
This construct was flanked by two arms of homology, which me-
diated homologous recombination with the endogenous locus in
C57BL/6-derived mouse embryonic stem (ES) cells (Artemis).
Identification of neomycin-resistant ES cell clones with a single
correct insertion was performed by Southern hybridization.
Two independently targeted clones were injected into C57BL/6
albino blastocysts to generate chimeric mice from which germ-
line-transmitted animals were obtained by crossing to C57BL/6
mice. Offspring were crossed with FLPe mice to remove the frt-
flanked PGK-neomycin sequence and obtain the mice used in
this study.
Timed matings and embryos
C-sections were performed to recover E13.5–E18.5 embryos for
histology and tissue harvest. Pictures were captured using a bin-
ocular microscope (Leica) equipped with a DFC495 digital
camera.
Peripheral blood analysis
Blood analysis was performedwith aHemavetHV960FS (Greiner)
for E18.5 embryos and a scilVetABCHematologyAnalyzer (GML)
for adult mice.
Flow cytometry and cell sorting
Unless otherwise stated, staining buffer phosphate buffered sa-
line (PBS) with 3% (v/v) fetal bovine serum (FBS; Gibco 10270-
106) was used for preparation, washing, and staining steps.
Single-cell suspensions were prepared by homogenizing spleen
through 70-µM filters (Falcon 352350), or flushing both femurs
and tibiae using a 23G needle. For erythrocyte lysis, splenocyte
suspensions were incubated for 3 min in lysis buffer (pH 7.5) on
ice (155 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA). Single-
cell suspensions were filtered through a 50-µM cup filcon cell
numbers were determined using a hemocytometer (Neubauer)
and trypan blue exclusion.
For ex vivo flow cytometry analysis, 3 × 106 cells per staining
were incubated with 1 µg/mL αCD16/32 Fc-Block (BioLegend
101320) for 10 min at 4°C and washed and stained for 20 min at
4°C with monoclonal antibody cocktails as detailed in the Sup-
plemental Materials and Methods. Apoptosis was assessed by re-
suspending cells inAnnexin-V-FITC (BioLegend 640945, 1:800) or
Annexin-V-eF450 (eBiosciences 48-8006-69, 1:1000) and 10 nM
TO-PRO-3 (Invitrogen T3605) in Annexin-V binding buffer
(BioLegend 422201) prior to analysis.
For intracellular BIM staining, 3 × 106 cells were cell-surface
stained as described above, fixed (BioLegend 420801), and per-
meabilized (BioLegend 421002) as per themanufacturer’s instruc-
tions. Cells were incubated with 2 µg/mL Fc-Block in 50 µL
permeabilization buffer at 4°C. After 30min, 50 µL antibody dilu-
tion (Abcam ab32158, 1:100) in permeabilization buffer was add-
ed and cells were incubated for 30 min. Cells were washed twice
with permeabilization buffer and incubated for 30 min with ei-
ther AlexaFluor-488 goat α-rabbit (Invitrogen A11034, 1:1000)
or AlexaFluor-647 goat α-rabbit (Invitrogen A21245, 1:1000) sec-
ondary antibody in 50 µL permeabilization buffer. Cells were
washed twice with permeabilization buffer and resuspended in
staining buffer.
Flow cytometry data were acquired on an LSRII cytometer (BD
Biosciences) and analyzed with the FlowJo software (Treestar).
Nonsinglet events were excluded based on characteristics of for-
ward and side scatter.
For cell sorting, single-cell suspensions were pre-incubated
with 2 µg/mL Fc-Block in 500 µL staining buffer for 10 min at
4°C and washed and stained for 20 min at 4°C with fluoro-
chrome-labeled antibodies in 500 µL staining buffer.
B cell culture
Primary B cells and Abl-B cells were cultured at 37°C in B
cell medium: DMEM (Sigma, WHMISDZB) supplemented with
miR-17∼92:Bim interactions are vital
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10% (v/v) FBS (Gibco 10270-106), 2 mM L-glutamine (Sigma
G7513), 10mMHEPES (LONZABE17-737E), 1mMsodiumpyru-
vate (Gibco 13360-039), nonessential amino acids (Gibco 11140-
035), 100 U/mL penicillin/100 µg/mL streptomycin (Sigma
0781), and 50 µM β-mercapto-ethanol (Sigma M3148).
Clonogenicity assay
Colony-forming assays were performed by plating 200,000 bone
marrow cells on semisolid medium containing IL-7 (Stem Cell
Technologies M3630) for pre-B cells, or by plating 20,000 bone
marrow cells on semisolid medium containing 10 ng/mL G-CSF
(Peprotech 250-05), 10 ng/mL M-CSF (Peprotech 315-02), 10 ng/
mL IL-3 (Peprotech 215-13), and 10 ng/mL IL-6 (Peprotech 216-
16) for myeloid progenitors (Stem Cell Technologies M3231) fol-
lowing the manufacturer’s instructions. Colony-forming units
were enumerated after 7 (preB) or 14 d (myeloid).
Quantitative RT-PCR
RNA of snap-frozen cell pellets or E18.5 lung tissue ground into
powder in liquid nitrogen was extracted using the miRNeasy
(QIAGEN 217004) or RNeasy mini kit (QIAGEN 74104) as per
the manufacturer’s instructions. cDNA was generated using the
Superscript III RNA reverse transcription kit (Invitrogen
18080044) as per themanufacturer’s instructions. cDNAwas am-
plified using a SYBR Green Universal PCR Master Mix (Applied
Biosystems 4309155) as per the manufacturer’s instructions.
qRT-PCR was performed on a StepOnePlus Real-time PCR
system (Applied Biosystems) using primer sequences detailed in
Supplemental Table S3 with the following cycle conditions:
95°C/10 min; 44 cycles: 95°C/15 sec, 60°C/60 sec. mRNA
expression was normalized and expressed relative to the endoge-
nous reference gene Hprt: fold induction=2(−ΔCt), where ΔCt =
Ct(target)–Ct(Hprt).
Immunoblotting
E18.5 lungs were ground into powder in liquid nitrogen and lysed
for 30 min in ice-cold extraction buffer (50 mMTris [pH 7.4], 150
mM NaCl, 0.5% NP-40, 50 mM NaF, 1 mM Na3VO4, 1 mM
PMSF, 100 µg/mL DNase I) completed with protease inhibitors
(Roche 11873580001). Lysates were centrifuged at 15,000 g for
20 min, and protein concentration was quantified using Bradford
Assay (Bio-Rad 500-0006). Protein extracts were denatured in
Laemmli buffer (50 mM Tris-HCL, 2% SDS, 10% glycerol,
0.1% bromphenolblue, 100 mM β-mercaptoethanol), boiled for
5 min, resolved by reducing SDS-polyacrylamide gel electropho-
resis (Tris-glycine 14% gel, 20 µg protein/lane), and transferred
onto a nitrocellulose membrane (GE Healthcare 10600004).
Membranes were blocked with 5% nonfat milk in PBS-T (PBS/
0.1%Tween) for 2 h and probedwith primary antibodies in block-
ing buffer overnight at 4°C. Membranes were washed and probed
with secondary antibodies in blocking buffer for 2 h at room tem-
perature. The following antibodies were used: Primary: α-BIM
(ENZO ALX-804-527, 1:500), α-PTEN (Cell Signaling 9559,
1:500), α-HSP90 (Santa Cruz 13119, 1:1000); Secondary: α-rabbit
Ig/HRP (Dako P0448, 1:10,000), α-mouse Ig/HRP (Dako P0161,
1:10,000), α-rat IgG/HRP (Cell Signaling 7077, 1:10,000).
Membranes were washed and incubated with an enhanced
chemiluminescence reagent (advanstaWestern Bright ECLSpray,
K-12049-D50) before exposure to an X-ray film (GE Healthcare
28906837).
Histology
H&E staining was performed on 7-µm sections from formalin-
fixed (4% paraformaldehyde/PBS) paraffin-embedded embryo
chests. Images were acquired on a Keyence BZ-9000 microscope
and processed with the Keyence BZ-II viewer software.
Skeletal preparations
E18.5 skeletons were prepared as described (Han et al. 2015). Pic-
tureswere capturedwith a binocularmicroscope (Leica) equipped
with a DFC495 digital camera.
nCounter miRNA gene expression profiling
Total RNA was extracted from snap-frozen Abl-B cells or E18.5
lung tissue ground into powder using the miRNeasy mini kit
(QIAGEN 217004). Relative miRNA copy number was deter-
mined using the nCounterMouse v1.5 miRNA Expression Assay
kit (NanoString Technologies GXA-MMIR15-12) and nCounter
SPRINT profiler (NanoString Technologies) as per the manufac-
turer’s instructions.
Sample preparation for PAR-CLIP
Abl-B cells were labeled with 500 µM 4-thiouridine (Carbosynth
13957-31-8) for 5 h and crosslinked at 365 nm with a total dose
of 2000 µJ/cm2 (UV Stratalinker 2400). Cell pellets were snap-fro-
zen in liquid nitrogen and stored at −80°C. PAR-CLIP was per-
formed as described in Hafner et al. (2010) with the following
modifications. Briefly, cells were lysed in NP-40 lysis buffer
(50 mM HEPES-KOH at pH 7.5, 150 mM KCl, 2 mM EDTA,
0.5% [v/v] NP40, 0.5 mM DTT, complete EDTA-free protease in-
hibitor cocktail). Lysates were incubated with protein Gmagnetic
beads (Invitrogen 100-03D) and precoupled to an α-mouse AGO2
antibody (Wako Chemicals 018-22021) for 1 h at 4°C. Beads were
washed with IP wash buffer (50 mM HEPES-KOH, pH 7.5,
150 mM KCl, 0.05% [v/v] NP40, 0.5 mM DTT, complete EDTA-
free protease inhibitor cocktail) and subjected to RNase T1 (Fer-
mentas EN0541) treatment (10U/µL) for 10min at 37°C. Immuno-
precipitations were washed in IP wash buffer and incubated with
calf intestinal phosphatase (New England BioLabs M0290), fol-
lowed by radioactive end-labeling usingT4 polynucleotide kinase
(New England BioLabsM0201). Protein-RNA complexes were re-
solved on a 4%–12%NuPAGE gel (InvitrogenWG1402BOX) and
transferred onto a nitrocellulose membrane. The protein-RNA
complexes at the expected molecular weight were excised. RNA
was isolated by Proteinase K (Roche 03115801001) treatment
and phenol-chloroform extraction, followed by adapter ligation
and cDNA library construction. The amplified cDNA was se-
quenced on an Illumina HiSeq2000 instrument.
PAR-CLIP data processing
The Illumina CASAVA (v1.8.2) software was used for RNAseq
base calling. RNAseq reads had 3′ adaptors trimmed in two passes
using (flexbar 2.5) with parameters: –adapter-relaxed –adapter-
trim-end RIGHT –max-uncalled 0 –adapter-gap -3 –format i1.8
–pre-trim-phred 30 –min-read-length 12. The reads were col-
lapsed with a custom script to remove PCR amplification biases
and consequently trimmed by 2 nt from both 5′ and 3′ ends to re-
move random nucleotides ligated with the adaptors. A reference
based onmm9was created that contained the corresponding Bim
3′ UTR mutations (mm9_Bim_MUT). Reads that did not map to
rRNA (NCBIM37.65 rRNA FASTA downloaded from BioMart)
were mapped to mm9 for the wild type and to mm9_Bim_MUT
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for the Bim3′UTRmut/mut libraries. Only alignments with a map-
ping quality of at least 13 were retained. For mapping, we used
bwa (0.7.12-r1039) in local alignment mode allowing for up to
three mismatches in the whole read (bwa aln -n 3 -l 100). Aligned
reads that contained RNAT:C conversions were processed using
a custom python script. Coverage plots were generated using
R and Bioconductor (Lawrence et al. 2013).
Identification of differentially covered miR-17∼92 sites
A list of 3′ UTRs was constructed by taking all transcripts in the
UCSC mm9 annotation incorporated by the TxDb.Mmusculu-
s.UCSC.mm9.knownGene Bioconductor package (version 3.2.2)
and identifying those that had a UniProt annotation using the
org.Mm.eg.db Bioconductor package (version 3.5.0) and a
3′ UTR of at least 50 nt. For each gene, the longest 3′ UTR across
all isoforms was selected. The 3′ UTR sequences were construct-
ed using the BSgenome.Mmusculus.UCSC.mm9 Bioconductor
genome package (version 1.4.0). A custom python script identi-
fied all perfectmiR-17∼92 seedmatches on them. The 3′ UTR co-
ordinates of a perfect binding site match were converted to
genomic coordinates, paying attention to cases of spliced
3′ UTRs. The identified binding sites were then queried using
the summarizeOverlaps function of the GenomicAlignments
Bioconductor package (version 1.14.2) in the IntersectionNo-
tEmpty mode for the amount of reads overlapping a window of
41 nt centered around them. Only windows covered by at least
five reads in at least one sample were kept. Differential coverage
was analyzed using the DESeq2 package (Love et al. 2014).
nCounter miRNA gene expression scatterplots
Raw miRNA counts were converted to CPM, counts per million
“mapped” (counted). Differential expression analysis was per-
formed using the DESeq2 package, and plots were generated
using R.
Statistical analysis
Images were analyzed and processed using Photoshop (Adobe),
ImageJ, the Keyence BZ-II viewer software, and Image Access En-
terprise 6. Graphs were plotted and statistical analysis was
performed with GraphPad Prism 7 software using Student’s un-
paired two-tailed t test when comparing two groups, one-way
ANOVA followed by Tukey post-hoc test when comparing mul-
tiple groups and a χ2 test for genotype frequencies. Results are
shown as mean and standard deviation (SD). Group and sample
sizes were empirically determined and the number of biological
repetitions (n) is stated in each figure legend. No randomization
or blinding protocol was used for experimental grouping.
Data availability
The PAR-CLIP sequencing, Abl-B cell, and E18.5 lung Nano-
String data have been deposited in NCBI’s Gene Expression Om-
nibus (GSE123673).
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